Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep >

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

   
Rohit Loomba at the 2018 AASLD Liver Meeting. Photo by Liz Highleyman.Rohit Loomba at the 2018 AASLD Liver Meeting. Photo by Liz Highleyman.

The Liver Meeting: NAFLD

Thyroid hormone receptor agonists reduce liver fat in people with NAFLD.

News from The Liver Meeting 2018

News from The Liver Meeting 2018

Read our 2018 Liver Meeting news bulletin.

Masatoshi Kudo, Kindai University, Osaka, presenting at the AASLD Liver Meeting 2018. Photo by Liz Highleyman. Masatoshi Kudo, Kindai University, Osaka, presenting at the AASLD Liver Meeting 2018. Photo by Liz Highleyman.

The Liver Meeting: Hepatocellular carcinoma

Nivolumab works well for liver cancer patients with advanced disease.

Alina Allen at The Liver Meeting 2018. Photo by Liz Highleyman.Alina Allen at The Liver Meeting 2018. Photo by Liz Highleyman.

The Liver Meeting: NAFLD and cancer

People with fatty liver disease are at greater risk for multiple cancers.

Kathleen Schwarz at The Liver Meeting 2018. Photo by Liz Highleyman.Kathleen Schwarz at The Liver Meeting 2018. Photo by Liz Highleyman.

The Liver Meeting: Treatment outcomes

Sofosbuvir/ledipasvir cures most young children with hepatitis C.

infohep news

Latest library resources

Looking for country specific news, resources and services?

Looking for country specific news, resources and services?

Visit our country information pages >

Keep up to date with the latest hepatitis news

Keep up to date with the latest hepatitis news

Sign up for our free monthly email bulletin >